Skip to main content
Equibles

MLEC · Moolec Science SA

Track MLEC — free

Use MLEC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MLEC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.10 -2.09 (-49.88%)
Rebalance outlook locked
Market Cap
$3.04M
Shares
726,118
Volume · Oct 9 176.58K Avg daily vol (3M) 17.2K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.19 Open$4.70 Day$4.19–4.83 52W close$3.38–17.10 Avg vol 30d23K Short int3K · 0.4% float · 1.0d Short vol38% Last earningsJun 30, 2024 DataMar 2021–Oct 2026

Up next

Q4 2024 earnings call transcript
call held Jun 30, 2024

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+948.3%
Year over year
Operating margin
-31.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.3%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.4%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Weak Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.62
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −44%
below
Price vs 50-day avg −35%
below
RSI (14) 28
oversold
MACD trend Negative
52-week position 6%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −43%
trailing
6-month return −47%
trailing
YTD return +10%
this year
Relative strength −56%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow Accumulating
+5% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.39% of float · ▼ -68.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
20 holders — 13F breadth
Squeeze score 28
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 207%
annualized · 1-yr
Max drawdown −76%
past year
ATR 13.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−44% Bearish
Price vs 50-day avg
−35% Bearish
RSI (14)
28 Neutral
MACD trend
Negative Bearish
52-week position
6% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow Accumulating
+5% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.39% of float · ▼ -68.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
20 holders — 13F breadth
Price context
position in its 52-week range
Range low $3 Now $4 · 6% Range high $17
vs 200-day avg -44% vs 50-day avg -35%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MLEC
Moolec Science SA
this stock
$3.04M — — — 0.4%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $127.55B +11.0% +46.2% 29.3 1.8%
MRNA
Moderna, Inc.
 $78.65B +568.0% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $76.14B -4.2% +20.8% 18.3 2.1%
CSLLY
Csl Ltd
 $61.58B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
20
% held
301.4%
Net QoQ
+113.6K sh
Top holder
Linden Advisors LP
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
2.8K
Days to cover
1.0d
Change
-6.1K sh
View
Short Volume
Short vol %
38%
As of
Oct 9, 2026
Short Total
View
Fails to Deliver
FTD shares
1.3K
Value
$8.9K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
59.8%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 7, 2026
This year
14
View
Earnings & Events
Webcasts
Last webcast
Jun 30, 2024
View

Performance

5D 20D 120D MTD YTD
MLEC -12.9% -43.3% -46.6% -14.1% +9.5%
SPY +1.3% +2.1% +9.0% +1.5% +13.5%
vs SPY -14.2% -45.4% -55.6% -15.6% -4.0%
Key facts CIK 1937737 CUSIP G6223S125 Visit website Investor relations